Captor Therapeutics

Captor Therapeutics is a high-tech pharmaceutical company focused on targeting the undruggable proteome. Our mission is to transform lives of patients suffering from cancer, viral infections, and inflammatory and neurodegenerative diseases. Our groundbreaking technology is perfectly suited to ease patients'​ burden and cure conditions that so far have only been poorly treatable.​

Our company is a pioneer of a small molecule-induced targeted degradation of proteins with particular expertise covering degradation of membrane proteins. We are privately held start-up with total of 65+ years of experience in pharmaceutical industry. We collaborate closely with renowned biology and chemistry experts from top American and European academic institutions.